Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemorrane Plus versus Hemorrane versus placebo in grade I-II hemorrhoids
2019-003024-20Phase 3Terminated
- Sponsor
- Faes Farma
- Start
- Aug 2019
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Hemorrane Plus, hydrocortisone and benzocaine in hemorrhoid (3 arms), sponsored by Faes Farma. Primary endpoint: Pain response at day 7. Started Aug 2019; status: terminated.
02
Drugs
Hemorrane Plushydrocortisonebenzocaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on 2019-003024-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003024-20.